Approval · Notice of Compliance 9640 · 2008
ZEFTERA: Notice of Compliance 9640
Issued June 26, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9640
- Date
- June 26, 2008
- Company
- Janssen-Ortho Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antibacterial agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZEFTERA | 02313103 | Cancelled Post Market |
Medicinal ingredients
- CEFTOBIPROLE MEDOCARIL 500 MG per VIAL